2 completed, 1 not yet recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Germ Cell Cancer: new trials by email Literature Review of Germ Cell Cancer trials Research Report on Germ Cell Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1/2 Study Of PARP Inhibition With Olaparib To Enhance The Efficacy Of High-Dose Chemotherapy In Refractory And Relapsed Germ Cell Tumors Olaparib, Gemcitabine, Docetaxel - Germ Cell Cancer | Phase 1 / Phase 2 | Not yet recruiting | M.D. Anderson Cancer Center | 36 | 2027-03-01 | 2026-10-01 |
| Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors Brentuximab Vedotin - Germ Cell Cancer | Phase 2 | Completed | Fondazione Michelangelo | 9 | 2013-05-01 | 2018-02-07 |
| Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer Everolimus - Testicular Cancer, Germ Cell Cancer | Phase 2 | Completed | Hannover Medical School | 25 | 2010-11-01 | 2015-02-25 |
Neoplasms, Germ Cell and Embryonal (3) · Testicular Neoplasms (2) · Carcinoma, Embryonal (1) · Neoplasm Metastasis (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Gonadal Disorders (2) · Male Urogenital Diseases (2) · Neoplasms by Site (2) · Testicular Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Neoplastic Processes (1) · Pathologic Processes (1)
Brentuximab Vedotin (1) · Carboplatin (1) · Docetaxel (1) · Etoposide (1) · Everolimus (1) · Gemcitabine (1) · etoposide phosphate (1) · olaparib (1)
Fondazione Michelangelo (1) · Hannover Medical School (1) · M.D. Anderson Cancer Center (1)
Germany (1) · Italy (1) · United States (1)
Alessandro M Gianni, MD (1) · Andrea Necchi, MD (1) · Martin H Fenner, MD (1) · Roberto Salvioni, MD (1) · Yago Nieto, MD, PHD (1)
2009 (1)